Rheumatoid Foot (BOFAS Revalidation) - Discussion

Description

In a professional setting, Nikki Kelsall addresses the audience to remind them to wear masks and invites questions to be posed at the microphones. An audience member appreciatively comments on the speakers and poses a technical question related to DMabs and surgery. Alan MacDonald responds, discussing the timing of stopping anti-TNFs before surgery, indicating potential flaring can occur within one to two weeks after cessation, emphasizing the pragmatic approach of stopping the medication at least two weeks prior to surgery. MacDonald highlights that while guidelines are not definitive, practical assessment is crucial, particularly concerning patients on rituximab. Another question from the audience pertains to intraocular inflammatory conditions, to which MacDonald admits his lack of expertise but suggests treatment interruptions could lead to complications like loss of sight.



Colin Patterson later addresses the practicality of anesthetic assessments, indicating the challenges in scheduling meetings with patients close to their surgical dates due to systemic delays in the healthcare process. He describes current practices at his facility and the challenge of balancing ideal patient care and practical realities, offering insights into how communication between surgeons and anesthetists can streamline patient management.



The dialogue continues with questions about the use of rocker bottom soles for foot problems in diabetic patients. Patterson advises on customizing treatment approaches based on the individual patient's condition, emphasizing that educated decision-making is vital for patient safety and stability. The session concludes with Kelsall acknowledging the audience's participation and transitioning to the next speakers.

DOI: 10.1302/3114-221470

Specialties